| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.54e-05 | 206 | 52 | 6 | GO:0140030 | |
| GeneOntologyMolecularFunction | histone binding | 6.30e-05 | 265 | 52 | 6 | GO:0042393 | |
| GeneOntologyMolecularFunction | phosphorylation-dependent protein binding | 2.95e-04 | 10 | 52 | 2 | GO:0140031 | |
| GeneOntologyMolecularFunction | methylated histone binding | 1.46e-03 | 86 | 52 | 3 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 1.56e-03 | 88 | 52 | 3 | GO:0140034 | |
| GeneOntologyMolecularFunction | ankyrin binding | 1.62e-03 | 23 | 52 | 2 | GO:0030506 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 1.77e-03 | 24 | 52 | 2 | GO:0008093 | |
| GeneOntologyBiologicalProcess | protein localization to M-band | 5.76e-06 | 2 | 50 | 2 | GO:0036309 | |
| GeneOntologyCellularComponent | costamere | 2.42e-05 | 22 | 54 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | Z disc | 4.38e-05 | 151 | 54 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 6.87e-05 | 166 | 54 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | sarcomere | 4.53e-04 | 249 | 54 | 5 | GO:0030017 | |
| GeneOntologyCellularComponent | myofibril | 6.87e-04 | 273 | 54 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | intercalated disc | 7.25e-04 | 68 | 54 | 3 | GO:0014704 | |
| GeneOntologyCellularComponent | COPII vesicle coat | 7.68e-04 | 16 | 54 | 2 | GO:0030127 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 9.01e-04 | 290 | 54 | 5 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcolemma | 1.47e-03 | 190 | 54 | 4 | GO:0042383 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.85e-03 | 94 | 54 | 3 | GO:0044291 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.96e-03 | 96 | 54 | 3 | GO:0070603 | |
| Domain | Znf_FCS | 7.56e-05 | 5 | 52 | 2 | IPR012313 | |
| Domain | Sec23/24_helical_dom | 1.13e-04 | 6 | 52 | 2 | IPR006900 | |
| Domain | Sec23_24_beta_S | 1.13e-04 | 6 | 52 | 2 | IPR012990 | |
| Domain | zf-Sec23_Sec24 | 1.13e-04 | 6 | 52 | 2 | PF04810 | |
| Domain | Sec23_trunk | 1.13e-04 | 6 | 52 | 2 | PF04811 | |
| Domain | Sec23_helical | 1.13e-04 | 6 | 52 | 2 | PF04815 | |
| Domain | Sec23_BS | 1.13e-04 | 6 | 52 | 2 | PF08033 | |
| Domain | ZF_FCS | 1.13e-04 | 6 | 52 | 2 | PS51024 | |
| Domain | Sec23/24_trunk_dom | 1.13e-04 | 6 | 52 | 2 | IPR006896 | |
| Domain | Znf_Sec23_Sec24 | 1.13e-04 | 6 | 52 | 2 | IPR006895 | |
| Domain | MBT | 2.70e-04 | 9 | 52 | 2 | SM00561 | |
| Domain | ZU5 | 2.70e-04 | 9 | 52 | 2 | SM00218 | |
| Domain | MBT | 2.70e-04 | 9 | 52 | 2 | PS51079 | |
| Domain | MBT | 3.37e-04 | 10 | 52 | 2 | PF02820 | |
| Domain | Mbt | 3.37e-04 | 10 | 52 | 2 | IPR004092 | |
| Domain | ZU5 | 3.37e-04 | 10 | 52 | 2 | PS51145 | |
| Domain | ZU5 | 4.93e-04 | 12 | 52 | 2 | PF00791 | |
| Domain | ZU5_dom | 4.93e-04 | 12 | 52 | 2 | IPR000906 | |
| Domain | Gelsolin | 6.77e-04 | 14 | 52 | 2 | PF00626 | |
| Domain | NPIP | 6.77e-04 | 14 | 52 | 2 | IPR009443 | |
| Domain | Gelsolin-like_dom | 6.77e-04 | 14 | 52 | 2 | IPR007123 | |
| Domain | PRAME_family | 1.26e-03 | 19 | 52 | 2 | IPR026271 | |
| Domain | ADF-H/Gelsolin-like_dom | 2.02e-03 | 24 | 52 | 2 | IPR029006 | |
| Domain | - | 2.02e-03 | 24 | 52 | 2 | 3.40.20.10 | |
| Domain | DEATH | 2.55e-03 | 27 | 52 | 2 | SM00005 | |
| Domain | Death | 3.80e-03 | 33 | 52 | 2 | PF00531 | |
| Domain | Death_domain | 5.01e-03 | 38 | 52 | 2 | IPR000488 | |
| Domain | MYB_LIKE | 5.01e-03 | 38 | 52 | 2 | PS50090 | |
| Domain | DEATH_DOMAIN | 5.01e-03 | 38 | 52 | 2 | PS50017 | |
| Domain | BROMODOMAIN_2 | 5.82e-03 | 41 | 52 | 2 | PS50014 | |
| Domain | BROMO | 6.10e-03 | 42 | 52 | 2 | SM00297 | |
| Domain | Bromodomain | 6.10e-03 | 42 | 52 | 2 | IPR001487 | |
| Domain | - | 6.10e-03 | 42 | 52 | 2 | 1.20.920.10 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 5.10e-05 | 156 | 37 | 5 | M27097 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 1.20e-04 | 187 | 37 | 5 | M961 | |
| Pubmed | ASNSD1 MBTD1 NOP16 L3MBTL2 SEC24A RECQL5 SEC24B BAZ1B GON4L KMT2A BCOR LARP4 MIDEAS TRIB1 PRRC2B RPL19 | 5.34e-10 | 1429 | 56 | 16 | 35140242 | |
| Pubmed | 2.21e-07 | 263 | 56 | 7 | 34702444 | ||
| Pubmed | MBTD1 PRAMEF5 PRR5L GALNT1 ANK3 OBSCN BAZ1B PLEC CCDC77 BCOR PRAMEF6 | 1.06e-06 | 1084 | 56 | 11 | 11544199 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.52e-06 | 351 | 56 | 7 | 38297188 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 11781319 | ||
| Pubmed | Structural basis of diverse membrane target recognitions by ankyrins. | 2.55e-06 | 2 | 56 | 2 | 25383926 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 36006564 | ||
| Pubmed | 2.68e-06 | 549 | 56 | 8 | 38280479 | ||
| Pubmed | POM121 GALNT1 PMPCA NOP16 SEC24A SEC24B GLUL TRAPPC8 LARP4 PRRC2B | 4.21e-06 | 1007 | 56 | 10 | 34597346 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MBTD1 ZBED4 NOP16 L3MBTL2 RECQL5 BAZ1B KMT2A SUZ12 BCOR MIDEAS RPL19 | 5.79e-06 | 1294 | 56 | 11 | 30804502 |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 21223964 | ||
| Pubmed | Human ankyrins and their contribution to disease biology: An update. | 7.63e-06 | 3 | 56 | 2 | 33410423 | |
| Pubmed | Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line. | 7.63e-06 | 3 | 56 | 2 | 18782775 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 12527750 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 15611082 | ||
| Pubmed | Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue. | 7.63e-06 | 3 | 56 | 2 | 34289389 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 8.60e-06 | 457 | 56 | 7 | 32344865 | |
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 22469984 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 27303043 | ||
| Pubmed | The role of the C-terminal domain of PCSK9 and SEC24 isoforms in PCSK9 secretion. | 1.52e-05 | 4 | 56 | 2 | 32058034 | |
| Pubmed | NOP16 DCTN5 CNEP1R1 RECQL5 SEC24B NCAPD2 BAZ1B GON4L KMT2A SUZ12 BCOR | 2.26e-05 | 1497 | 56 | 11 | 31527615 | |
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 25950943 | ||
| Pubmed | Glial ankyrins facilitate paranodal axoglial junction assembly. | 2.54e-05 | 5 | 56 | 2 | 25362471 | |
| Pubmed | An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan. | 2.54e-05 | 5 | 56 | 2 | 19109891 | |
| Pubmed | 3.47e-05 | 39 | 56 | 3 | 22802532 | ||
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 10075675 | ||
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 3.80e-05 | 6 | 56 | 2 | 23728480 | |
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 10329445 | ||
| Pubmed | 4.04e-05 | 41 | 56 | 3 | 8590280 | ||
| Pubmed | 4.34e-05 | 42 | 56 | 3 | 35705031 | ||
| Pubmed | Selective export of human GPI-anchored proteins from the endoplasmic reticulum. | 5.32e-05 | 7 | 56 | 2 | 20427317 | |
| Pubmed | Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice. | 5.32e-05 | 7 | 56 | 2 | 7495297 | |
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 21135039 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 5.32e-05 | 608 | 56 | 7 | 36089195 | |
| Pubmed | 5.72e-05 | 615 | 56 | 7 | 31048545 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 6.32e-05 | 1105 | 56 | 9 | 35748872 | |
| Pubmed | 6.91e-05 | 49 | 56 | 3 | 20471030 | ||
| Pubmed | Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway. | 7.09e-05 | 8 | 56 | 2 | 28826662 | |
| Pubmed | SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion. | 7.09e-05 | 8 | 56 | 2 | 23580231 | |
| Pubmed | 8.32e-05 | 653 | 56 | 7 | 22586326 | ||
| Pubmed | 8.42e-05 | 449 | 56 | 6 | 31732153 | ||
| Pubmed | ZBED4, a cone and Müller cell protein in human retina, has a different cellular expression in mouse. | 9.10e-05 | 9 | 56 | 2 | 21850176 | |
| Pubmed | Potent and specific Atg8-targeting autophagy inhibitory peptides from giant ankyrins. | 9.10e-05 | 9 | 56 | 2 | 29867141 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 9.24e-05 | 146 | 56 | 4 | 23892456 | |
| Pubmed | 9.74e-05 | 148 | 56 | 4 | 35676246 | ||
| Pubmed | The transport signal on Sec22 for packaging into COPII-coated vesicles is a conformational epitope. | 1.14e-04 | 10 | 56 | 2 | 17499046 | |
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 1.14e-04 | 10 | 56 | 2 | 22159418 | |
| Pubmed | 1.14e-04 | 10 | 56 | 2 | 20569692 | ||
| Pubmed | Structural basis of cargo membrane protein discrimination by the human COPII coat machinery. | 1.14e-04 | 10 | 56 | 2 | 18843296 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.19e-04 | 934 | 56 | 8 | 33916271 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | MBTD1 PRAMEF5 L3MBTL2 DCTN5 SEC24A BAZ1B CCDC77 PRRC2B PRAMEF6 | 1.53e-04 | 1242 | 56 | 9 | 30973865 |
| Pubmed | 1.61e-04 | 65 | 56 | 3 | 22496869 | ||
| Pubmed | Planar cell polarity defects and defective Vangl2 trafficking in mutants for the COPII gene Sec24b. | 1.66e-04 | 12 | 56 | 2 | 20215345 | |
| Pubmed | 1.96e-04 | 13 | 56 | 2 | 18308860 | ||
| Pubmed | 1.97e-04 | 332 | 56 | 5 | 37433992 | ||
| Pubmed | 1.98e-04 | 1006 | 56 | 8 | 15226823 | ||
| Pubmed | 2.17e-04 | 339 | 56 | 5 | 30415952 | ||
| Pubmed | 2.29e-04 | 14 | 56 | 2 | 20854876 | ||
| Pubmed | 2.29e-04 | 14 | 56 | 2 | 12702772 | ||
| Pubmed | 2.51e-04 | 1327 | 56 | 9 | 32694731 | ||
| Pubmed | Ankyrin-G regulated epithelial phenotype is required for mouse lens morphogenesis and growth. | 2.64e-04 | 15 | 56 | 2 | 30562487 | |
| Pubmed | 2.80e-04 | 195 | 56 | 4 | 19454010 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 2.89e-04 | 1353 | 56 | 9 | 29467282 | |
| Pubmed | 3.19e-04 | 1371 | 56 | 9 | 36244648 | ||
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 3.41e-04 | 17 | 56 | 2 | 23565261 | |
| Pubmed | 3.41e-04 | 17 | 56 | 2 | 37781892 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 3.61e-04 | 588 | 56 | 6 | 38580884 | |
| Pubmed | 3.71e-04 | 210 | 56 | 4 | 16565220 | ||
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 3.83e-04 | 18 | 56 | 2 | 29731491 | |
| Pubmed | 3.83e-04 | 18 | 56 | 2 | 23894331 | ||
| Pubmed | 3.83e-04 | 18 | 56 | 2 | 14675769 | ||
| Pubmed | 3.83e-04 | 18 | 56 | 2 | 37321992 | ||
| Pubmed | Ecm29-mediated proteasomal distribution modulates excitatory GABA responses in the developing brain. | 3.83e-04 | 18 | 56 | 2 | 31910261 | |
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 3.83e-04 | 18 | 56 | 2 | 12890732 | |
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 3.83e-04 | 18 | 56 | 2 | 39181896 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 4.25e-04 | 853 | 56 | 7 | 28718761 | |
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 4.28e-04 | 19 | 56 | 2 | 28604677 | |
| Pubmed | 4.28e-04 | 19 | 56 | 2 | 19656773 | ||
| Pubmed | 4.61e-04 | 1442 | 56 | 9 | 35575683 | ||
| Pubmed | 4.75e-04 | 20 | 56 | 2 | 30596474 | ||
| Pubmed | 4.75e-04 | 20 | 56 | 2 | 26694250 | ||
| Pubmed | 4.75e-04 | 20 | 56 | 2 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 4.75e-04 | 20 | 56 | 2 | 21425410 | |
| Pubmed | 5.01e-04 | 407 | 56 | 5 | 12693553 | ||
| Pubmed | EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway. | 5.24e-04 | 21 | 56 | 2 | 33029523 | |
| Pubmed | The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size. | 5.24e-04 | 21 | 56 | 2 | 27088858 | |
| Pubmed | 5.58e-04 | 234 | 56 | 4 | 36243803 | ||
| Pubmed | 5.76e-04 | 22 | 56 | 2 | 31729367 | ||
| Pubmed | 5.87e-04 | 645 | 56 | 6 | 25281560 | ||
| Pubmed | 5.89e-04 | 101 | 56 | 3 | 10997877 | ||
| Pubmed | 6.24e-04 | 103 | 56 | 3 | 32744500 | ||
| Pubmed | 6.30e-04 | 23 | 56 | 2 | 17203973 | ||
| Pubmed | Cytokinesis involves a nontranscriptional function of the Hippo pathway effector YAP. | 6.30e-04 | 23 | 56 | 2 | 26933062 | |
| Pubmed | 6.30e-04 | 23 | 56 | 2 | 19480014 | ||
| Pubmed | 6.30e-04 | 23 | 56 | 2 | 31281901 | ||
| Pubmed | 6.87e-04 | 24 | 56 | 2 | 33722704 | ||
| Pubmed | 7.25e-04 | 251 | 56 | 4 | 28077445 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 7.42e-04 | 444 | 56 | 5 | 34795231 | |
| Pubmed | 7.46e-04 | 25 | 56 | 2 | 37451217 | ||
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 7.46e-04 | 25 | 56 | 2 | 12620990 | |
| Interaction | RNF43 interactions | ASNSD1 POM121 ANK3 SEC24A SEC24B OBSCN CCDC77 LARP4 RNF43 PRRC2B | 1.42e-07 | 427 | 53 | 10 | int:RNF43 |
| Interaction | KLF16 interactions | 1.41e-05 | 425 | 53 | 8 | int:KLF16 | |
| Interaction | H2BC8 interactions | 1.73e-05 | 576 | 53 | 9 | int:H2BC8 | |
| Interaction | EYA4 interactions | 4.13e-05 | 243 | 53 | 6 | int:EYA4 | |
| Cytoband | 18q12.1 | 4.66e-04 | 26 | 56 | 2 | 18q12.1 | |
| Cytoband | 1p36.21 | 2.72e-03 | 63 | 56 | 2 | 1p36.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p13 | 2.89e-03 | 65 | 56 | 2 | chr11p13 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 1.30e-04 | 9 | 35 | 2 | 1263 | |
| GeneFamily | PRAME family | 9.78e-04 | 24 | 35 | 2 | 686 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 4.21e-03 | 50 | 35 | 2 | 721 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.72e-03 | 53 | 35 | 2 | 532 | |
| GeneFamily | Ankyrin repeat domain containing | 1.13e-02 | 242 | 35 | 3 | 403 | |
| GeneFamily | PHD finger proteins | 1.31e-02 | 90 | 35 | 2 | 88 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | FOXM1 PRAMEF5 GALNT1 PMPCA SPHKAP SEC24B BAZ1B SUZ12 PRAMEF6 | 1.79e-06 | 543 | 55 | 9 | MM997 |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.49e-06 | 184 | 56 | 5 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.41e-06 | 193 | 56 | 5 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 4.44e-05 | 156 | 56 | 4 | 63b8cf14361b282872bc1c5b65d9fbc83e81a089 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.55e-05 | 157 | 56 | 4 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.66e-05 | 158 | 56 | 4 | 1bf692f1e85f677cd62805437b7a59cfaf3b0449 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.39e-05 | 164 | 56 | 4 | 30c3c25b05a403a509b2e755c2f0878fecb10a02 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.06e-05 | 169 | 56 | 4 | c3bf0cb67f200d02d5a021754e9b2a68d23ea168 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 169 | 56 | 4 | 81bbdcf1fdf5cad5bfe7a559af196ad0d8e18c35 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.06e-05 | 169 | 56 | 4 | 5375eb52ebadccb7bfff997a11985f23e81014d6 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.06e-05 | 169 | 56 | 4 | 1c132d21255f5a5174ac38db4e91927f9093418e | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 169 | 56 | 4 | b7db33be24a6a9386e277c2f8949551e4d259305 | |
| ToppCell | T_cells-GNLY+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 6.34e-05 | 171 | 56 | 4 | 04c811817cfec45af5f2891793106cc7ddb0300e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-05 | 172 | 56 | 4 | a3bcf0d432d8fccce50248e8d0c7a4804d69bfee | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-05 | 172 | 56 | 4 | 976d27edd5608616830624907fe050fcd3551865 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-05 | 172 | 56 | 4 | adf016e5856bc85e7bed58aee09ade483b9dcb00 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-05 | 174 | 56 | 4 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-05 | 174 | 56 | 4 | 3f0a5ce074675d57d479fa069385a1b3071e884e | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 176 | 56 | 4 | 4478b3284201220e902bd2077960dc0d4d4a2c7c | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-05 | 176 | 56 | 4 | 828ca4d55d726f82f90293c3c7eba081ea3ab92e | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 178 | 56 | 4 | cd0c5f15e6b28ce2208346279ee9503d18d9b27d | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 178 | 56 | 4 | 813d121a45e0416de1f26862851f6f0bda7ba43c | |
| ToppCell | COVID-19_Convalescent-PLT_1|World / Disease Group and Platelet Clusters | 7.57e-05 | 179 | 56 | 4 | d0f2764c6fc5d61fd69e9231b3603a80ac373f65 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 185 | 56 | 4 | c9ab7a3584d25f0ed73b20919c3dba00f502eac4 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.60e-05 | 185 | 56 | 4 | d42f6722a6771752cd744146a09e2ead9b7252bc | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 8.60e-05 | 185 | 56 | 4 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 187 | 56 | 4 | 1387981d224cb9e846ed18e366736855a4eb827e | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 9.34e-05 | 189 | 56 | 4 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 9.53e-05 | 190 | 56 | 4 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.53e-05 | 190 | 56 | 4 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 9.53e-05 | 190 | 56 | 4 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 9.73e-05 | 191 | 56 | 4 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 9.73e-05 | 191 | 56 | 4 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.73e-05 | 191 | 56 | 4 | fda432a7f79664e8ffd5d03c1c69ec43bbac994b | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 9.92e-05 | 192 | 56 | 4 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.92e-05 | 192 | 56 | 4 | 78546a6e077076834fd717607610ab6df3b6e7ba | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4|Lung / Manually curated celltypes from each tissue | 9.92e-05 | 192 | 56 | 4 | fd19cd0b5330448bef8debd753285adbc8b958a2 | |
| ToppCell | lymphoid-NK_cell-NK_cell|World / Lineage, cell class and subclass | 1.03e-04 | 194 | 56 | 4 | 7f5adc18e632109694446b8eb1543cbae62dccbe | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.03e-04 | 194 | 56 | 4 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.05e-04 | 195 | 56 | 4 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 195 | 56 | 4 | 497d4bfbc38bcafab37e8a9c20bc9141f2e78d2a | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.05e-04 | 195 | 56 | 4 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.05e-04 | 195 | 56 | 4 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 195 | 56 | 4 | 9c71d2a58e772b556e22e2f1d60593580b7aafd8 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.10e-04 | 197 | 56 | 4 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-04 | 197 | 56 | 4 | 5bd2f32137fd849931e52093d630d2e7e27daf4f | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-04 | 197 | 56 | 4 | d9baa0be469fd8737a74b5078d30ce7d66759160 | |
| ToppCell | medial-2-Hematologic-Myeloid_Dendritic_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-04 | 197 | 56 | 4 | 3c1147857de6a7ab6b0cf77f5a6364d4c8669693 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.10e-04 | 197 | 56 | 4 | 63d0f06e150e7eb800ecb70e97b9d12a01c84e37 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 198 | 56 | 4 | d5e91d1057e71b6a336eec95e44b2e7fe6b2c6ef | |
| ToppCell | Control_saline-Hematopoietic_Lymphocytic-Lymphocytic_NK/T|Control_saline / Treatment groups by lineage, cell group, cell type | 1.12e-04 | 198 | 56 | 4 | 9663cf0c8296d3a7b0329cb725ccceeea7849cbc | |
| ToppCell | Control_saline-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells|Control_saline / Treatment groups by lineage, cell group, cell type | 1.12e-04 | 198 | 56 | 4 | 42c855e313d574ef37c2353e4d69809146c391ff | |
| ToppCell | LPS_IL1RA-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.14e-04 | 199 | 56 | 4 | 9382abe4ca553bc4db12e413be921b626e56f2ac | |
| ToppCell | distal-2-Hematologic-Natural_Killer|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 199 | 56 | 4 | 77cc79c612c56022b37c8f690363c9ac8776e9cf | |
| ToppCell | medial-Hematologic-Natural_Killer|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 199 | 56 | 4 | 4a75ef6a3b7b5d779a08d039a79322cd60b4ef65 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.14e-04 | 199 | 56 | 4 | 618dc6425bb7b84d3b2de7cf8ecb41549a255718 | |
| ToppCell | medial-2-Hematologic-Natural_Killer|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 199 | 56 | 4 | 52338b8970fba0b32578748ba0bec0b344171ca6 | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells|LPS_only / Treatment groups by lineage, cell group, cell type | 1.14e-04 | 199 | 56 | 4 | bd7f03bef4660c347da5f16db34d91d563908448 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.14e-04 | 199 | 56 | 4 | 46e2d2962cd5b0f76baf976c0f6ecce117827274 | |
| ToppCell | medial-Hematologic-Natural_Killer-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 199 | 56 | 4 | dfcc4976688c7e6df5e41ae77436710075f1f779 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.14e-04 | 199 | 56 | 4 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Lymphocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.14e-04 | 199 | 56 | 4 | 5611b9e405a685a7a099d2f2d21dee3a939c2911 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 56 | 4 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD4+_T_naive|Int-URO / Disease, condition lineage and cell class | 1.16e-04 | 200 | 56 | 4 | a4b531355e87efd6b69a16eeec8b1ff14c7af750 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 56 | 4 | 7eed3d932018d6a87ce37d013883b371db55caeb | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 1.16e-04 | 200 | 56 | 4 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 56 | 4 | 56d738ff019682af7f1f8cbe7b262a75dc8596d5 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 200 | 56 | 4 | 0f8e2fed93cc103b20a825d8d3e83787c5c015cc | |
| ToppCell | distal-Hematologic-Natural_Killer|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-04 | 200 | 56 | 4 | 33947befb9d32ec00f9f3e7eedaac478dcd63b20 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 56 | 4 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | lymphoid-T_cell-pro-T_cell|World / Lineage, cell class and subclass | 1.40e-04 | 80 | 56 | 3 | 9bd3ad5029eb84efcdbf08fe268c29fa9b0b302b | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-04 | 107 | 56 | 3 | 410b37beffaf637a2a64c9d0ce7baf81f4bc667c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-04 | 107 | 56 | 3 | 5bae4b3aede9bcbf7e88414e3453973cc8b0c3e7 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 121 | 56 | 3 | e82c9e10b98c8d7ad828cf8ac19a2342014be2ba | |
| ToppCell | Endothelial-Endothelial-A|Endothelial / shred on cell class and cell subclass (v4) | 4.86e-04 | 122 | 56 | 3 | 65849d1296934d5765afd006cbb6739383b9f49f | |
| ToppCell | IIH-CD4-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 6.95e-04 | 138 | 56 | 3 | e474a0785a651020156baacbf89c4d2b1e4cc473 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|healthy_donor / Disease condition, Lineage, Cell class and subclass | 6.95e-04 | 138 | 56 | 3 | 97f5dc17522462133e582b508ad0ef036e656872 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-MyoFB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.40e-04 | 141 | 56 | 3 | 7ae8ead02e5aeb4106c4a30c08a7a061da3a5d6a | |
| ToppCell | control-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.18e-04 | 146 | 56 | 3 | 69e9c1ec6eec1151290227902e75e77a4aecc8db | |
| ToppCell | 15-Trachea-Immune-Immune|Trachea / Age, Tissue, Lineage and Cell class | 8.18e-04 | 146 | 56 | 3 | ca722a89c6601e78f253d9484d01931f26161820 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.68e-04 | 149 | 56 | 3 | 14d2e8cab97108d8fa94e540c1957b73ed32dc73 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.68e-04 | 149 | 56 | 3 | 54c9c6282f5f5de43dfaf2972fab3e3dcf9838a3 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-4|TCGA-Bladder / Sample_Type by Project: Shred V9 | 8.85e-04 | 150 | 56 | 3 | bcb99c6fa81052556ab30f9db5875fccf1ae724b | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 9.02e-04 | 151 | 56 | 3 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | Lymphoid|World / shred on cell class and cell subclass (v4) | 9.02e-04 | 151 | 56 | 3 | d7577b2416b91a8be0198dea703385f86f816059 | |
| ToppCell | COVID-CD4-proli_CD4|COVID / Condition, Cell_class and T cell subcluster | 9.02e-04 | 151 | 56 | 3 | dd40dfc5b1211d31607e16d9b433a5c1796e7edf | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.37e-04 | 153 | 56 | 3 | 82a96ca1912858c4311b87b3b0ba5a0a41e564b5 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.91e-04 | 156 | 56 | 3 | 0f2147abcf31a26ee5b2f4d8c5d72232612a33f0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.91e-04 | 156 | 56 | 3 | cb87f12443fdc5538b856f765fcbac9406044e10 | |
| ToppCell | T_cells-GNLY+GZMB+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.01e-03 | 157 | 56 | 3 | e9eb56a1dd96bd2e9725a20f2cf70ddeab811bd6 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-03 | 158 | 56 | 3 | 0ed844ab625351a46b74edddf082279ed1bae5c6 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-03 | 158 | 56 | 3 | b3a810314e253b4fd0f578e759c36fdd21722934 | |
| ToppCell | Club_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-03 | 159 | 56 | 3 | a7bcff268b1962a561fd2848e01ae16565bce895 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-03 | 159 | 56 | 3 | 656aa20706bdba81bbcc3e68e6058215b92b8802 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_Cytotoxic_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.05e-03 | 159 | 56 | 3 | 2060e7ed5627976b48fea4a2328762b6fa308db1 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-7|TCGA-Liver / Sample_Type by Project: Shred V9 | 1.05e-03 | 159 | 56 | 3 | 70288df54adab167c0f50675128619299077db11 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-03 | 161 | 56 | 3 | 441ebd3c029861d833fbcf8a68fc740d9de8ef2f | |
| ToppCell | 343B-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-03 | 161 | 56 | 3 | 537a1d86de99a493b0345ca0f760994260e97049 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.08e-03 | 161 | 56 | 3 | 2849fbc9611af208241b33da3cd18290aafe426b | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD4_Naive|ICU-SEP / Disease, Lineage and Cell Type | 1.12e-03 | 163 | 56 | 3 | 415e67aaae7ccd97a003b4b31b27eed94737deca | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-03 | 164 | 56 | 3 | 0662cd9d21608efacc336e0a582859f3b9a4951d | |
| Disease | Weaver syndrome | 3.04e-05 | 5 | 52 | 2 | C0265210 | |
| Disease | growth rate measurement | 1.66e-04 | 11 | 52 | 2 | EFO_0010572 | |
| Disease | stomach carcinoma (is_implicated_in) | 1.99e-04 | 12 | 52 | 2 | DOID:5517 (is_implicated_in) | |
| Disease | Hypertriglyceridemia | 5.11e-04 | 19 | 52 | 2 | EFO_0004211 | |
| Disease | sensory peripheral neuropathy, remission | 7.53e-04 | 23 | 52 | 2 | EFO_0009785, MONDO_0002321 | |
| Disease | Anhedonia | 8.20e-04 | 24 | 52 | 2 | C0178417 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 8.38e-04 | 239 | 52 | 4 | EFO_0010934 | |
| Disease | right ventricular ejection fraction measurement | 1.28e-03 | 30 | 52 | 2 | EFO_0021816 | |
| Disease | aseptic loosening, revision of total knee arthroplasty | 2.51e-03 | 42 | 52 | 2 | EFO_0010725, EFO_0020972 | |
| Disease | liver fat measurement | 2.63e-03 | 43 | 52 | 2 | EFO_0010821 | |
| Disease | schizophrenia (is_marker_for) | 2.75e-03 | 44 | 52 | 2 | DOID:5419 (is_marker_for) | |
| Disease | Mood Disorders | 3.27e-03 | 168 | 52 | 3 | C0525045 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAVILHVKRRRICVS | 61 | Q9NRJ3 | |
| RRRTIHTFPCLKELC | 151 | Q86X02 | |
| CSSPKIRRLEHRGRR | 101 | A0A0U1RQF7 | |
| RLRPRKTIRGKHSVI | 1281 | Q9UIG0 | |
| RHRARVLLISKLSCV | 166 | P32248 | |
| THTPVCRKRTVVSKR | 6 | Q9BR77 | |
| RLCKTKHLIPQESRR | 1361 | Q6W2J9 | |
| ARRPKRTIHIDCEKR | 151 | Q96I13 | |
| SPHIRLRLSKLRRCV | 161 | Q04671 | |
| PTRVTCRLVKRHRLA | 1001 | Q01484 | |
| RTHRLRKLRTPAKCR | 701 | Q92619 | |
| PRLICVATVTRIIHR | 506 | Q05BQ5 | |
| RLICVATVKRVVHRL | 551 | Q969R5 | |
| RRHRGLVKRKPQACL | 151 | Q8NAA5 | |
| RCQTKLHPLRSALRL | 131 | Q6DN72 | |
| PKRRRLSKLRTRHCT | 391 | O75200 | |
| KRRRLSKLRTRHCTQ | 401 | A6NHN6 | |
| TLARRHSRVRPKVTV | 236 | Q6MZQ0 | |
| RNHLVICKPRRDSRT | 5926 | Q5VST9 | |
| PLSSFVRKARHRRTL | 91 | Q96HA1 | |
| PLLARIKHDRRTVVC | 221 | Q10472 | |
| SRARVKTRDRTCPVH | 2081 | Q3T8J9 | |
| APTRITCRLVKRHKL | 1016 | Q12955 | |
| RVGRHCVVKSRSVIR | 56 | Q9BTE1 | |
| KVRPSHKRCIVILRE | 191 | Q71RC2 | |
| HKPSVIVTRRRSTRI | 561 | Q6PJG2 | |
| RRTRICHLIRPLDTV | 441 | Q9NWL6 | |
| RSRSRRKQHLLPPCV | 541 | Q08050 | |
| TSVRGPRIKHVCRRA | 1061 | Q03164 | |
| RVTLKVSSRIPHRLS | 31 | Q49AJ0 | |
| RRIRVHTLCLPVVSS | 991 | O95487 | |
| PKRRRLSKLRTRHCT | 406 | F8W1W9 | |
| CREPKISDLVRRRVL | 346 | Q6UXH9 | |
| PRCRKEARRLQALHE | 806 | Q9H0X9 | |
| RRPAETNLRHTCKRI | 106 | P15104 | |
| TRSRKLPHELCTLIR | 456 | Q10713 | |
| HKRRSLCSREVPLIQ | 1416 | Q2M3C7 | |
| ITRKCPRSNRIHRQK | 341 | Q9UIK5 | |
| RRIRVHTLCLPVVST | 816 | O95486 | |
| IRKPVTVHSRARCRK | 51 | P84098 | |
| SVLRIRCRPRHSRPD | 216 | Q68DV7 | |
| HKRVVAPSIIAARCR | 86 | Q8N9A8 | |
| ARRKAAPRIECSHIR | 26 | Q9Y3C1 | |
| VLRACTRRVLLRPEK | 431 | P34969 | |
| KKTTPILRASARRHR | 1386 | Q15021 | |
| RIPRLTVKAREHCLR | 541 | O94762 | |
| RVRDLRHPKRILFCT | 441 | Q5VXH4 | |
| HISPKARCLIRSLLR | 306 | Q96RU8 | |
| SHPLSRKSIPRCRRI | 36 | Q9P2N2 | |
| KRTPITHILVCRPKR | 521 | Q15022 | |
| RVRDLRHPKRILFCT | 441 | Q5TYX0 | |
| CPRAKPRRRVASETH | 1121 | Q5JSZ5 | |
| CETRTVHRLRLPLDK | 1136 | Q15149 | |
| RVPVLRSCRVHLSEK | 131 | Q6PK81 | |
| KIRHRILRHTAIICT | 1061 | Q9Y2L5 | |
| SLARKICERVHRSPK | 851 | O75132 |